vs

Side-by-side financial comparison of PATRICK INDUSTRIES INC (PATK) and Revvity (RVTY). Click either name above to swap in a different company.

PATRICK INDUSTRIES INC is the larger business by last-quarter revenue ($924.2M vs $772.1M, roughly 1.2× Revvity). Revvity runs the higher net margin — 12.7% vs 3.1%, a 9.6% gap on every dollar of revenue. On growth, PATRICK INDUSTRIES INC posted the faster year-over-year revenue change (9.2% vs 5.9%). Revvity produced more free cash flow last quarter ($161.8M vs $112.7M). Over the past eight quarters, Revvity's revenue compounded faster (9.0% CAGR vs -0.5%).

Anduril Industries, Inc. is an American defense technology company specializing in the development of advanced autonomous systems.

Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.

PATK vs RVTY — Head-to-Head

Bigger by revenue
PATK
PATK
1.2× larger
PATK
$924.2M
$772.1M
RVTY
Growing faster (revenue YoY)
PATK
PATK
+3.4% gap
PATK
9.2%
5.9%
RVTY
Higher net margin
RVTY
RVTY
9.6% more per $
RVTY
12.7%
3.1%
PATK
More free cash flow
RVTY
RVTY
$49.1M more FCF
RVTY
$161.8M
$112.7M
PATK
Faster 2-yr revenue CAGR
RVTY
RVTY
Annualised
RVTY
9.0%
-0.5%
PATK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PATK
PATK
RVTY
RVTY
Revenue
$924.2M
$772.1M
Net Profit
$29.1M
$98.4M
Gross Margin
23.0%
Operating Margin
6.2%
14.5%
Net Margin
3.1%
12.7%
Revenue YoY
9.2%
5.9%
Net Profit YoY
99.7%
3.9%
EPS (diluted)
$0.82
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PATK
PATK
RVTY
RVTY
Q4 25
$924.2M
$772.1M
Q3 25
$975.6M
$698.9M
Q2 25
$1.0B
$720.3M
Q1 25
$1.0B
$664.8M
Q4 24
$846.1M
$729.4M
Q3 24
$919.4M
$684.0M
Q2 24
$1.0B
$691.7M
Q1 24
$933.5M
$649.9M
Net Profit
PATK
PATK
RVTY
RVTY
Q4 25
$29.1M
$98.4M
Q3 25
$35.3M
$46.7M
Q2 25
$32.4M
$53.9M
Q1 25
$38.2M
$42.2M
Q4 24
$14.6M
$94.6M
Q3 24
$40.9M
$94.4M
Q2 24
$47.9M
$55.4M
Q1 24
$35.1M
$26.0M
Gross Margin
PATK
PATK
RVTY
RVTY
Q4 25
23.0%
Q3 25
22.6%
53.6%
Q2 25
23.9%
54.5%
Q1 25
22.8%
56.5%
Q4 24
22.1%
Q3 24
23.1%
56.3%
Q2 24
22.8%
55.7%
Q1 24
21.9%
54.6%
Operating Margin
PATK
PATK
RVTY
RVTY
Q4 25
6.2%
14.5%
Q3 25
6.8%
11.7%
Q2 25
8.3%
12.6%
Q1 25
6.5%
10.9%
Q4 24
4.7%
16.3%
Q3 24
8.1%
14.3%
Q2 24
8.3%
12.4%
Q1 24
6.4%
6.8%
Net Margin
PATK
PATK
RVTY
RVTY
Q4 25
3.1%
12.7%
Q3 25
3.6%
6.7%
Q2 25
3.1%
7.5%
Q1 25
3.8%
6.4%
Q4 24
1.7%
13.0%
Q3 24
4.4%
13.8%
Q2 24
4.7%
8.0%
Q1 24
3.8%
4.0%
EPS (diluted)
PATK
PATK
RVTY
RVTY
Q4 25
$0.82
$0.86
Q3 25
$1.01
$0.40
Q2 25
$0.96
$0.46
Q1 25
$1.11
$0.35
Q4 24
$-1.44
$0.77
Q3 24
$1.80
$0.77
Q2 24
$2.16
$0.45
Q1 24
$1.59
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PATK
PATK
RVTY
RVTY
Cash + ST InvestmentsLiquidity on hand
$26.4M
$919.9M
Total DebtLower is stronger
$1.3B
Stockholders' EquityBook value
$1.2B
$7.3B
Total Assets
$3.1B
$12.2B
Debt / EquityLower = less leverage
1.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PATK
PATK
RVTY
RVTY
Q4 25
$26.4M
$919.9M
Q3 25
$20.7M
$931.4M
Q2 25
$22.0M
$991.8M
Q1 25
$86.6M
$1.1B
Q4 24
$33.6M
$1.2B
Q3 24
$52.6M
$1.2B
Q2 24
$44.0M
$2.0B
Q1 24
$17.6M
$1.7B
Total Debt
PATK
PATK
RVTY
RVTY
Q4 25
$1.3B
Q3 25
Q2 25
Q1 25
Q4 24
$1.3B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PATK
PATK
RVTY
RVTY
Q4 25
$1.2B
$7.3B
Q3 25
$1.2B
$7.4B
Q2 25
$1.1B
$7.6B
Q1 25
$1.1B
$7.6B
Q4 24
$1.1B
$7.7B
Q3 24
$1.1B
$7.9B
Q2 24
$1.1B
$7.9B
Q1 24
$1.1B
$7.8B
Total Assets
PATK
PATK
RVTY
RVTY
Q4 25
$3.1B
$12.2B
Q3 25
$3.1B
$12.1B
Q2 25
$3.1B
$12.4B
Q1 25
$3.2B
$12.4B
Q4 24
$3.0B
$12.4B
Q3 24
$3.1B
$12.8B
Q2 24
$3.0B
$13.4B
Q1 24
$3.0B
$13.4B
Debt / Equity
PATK
PATK
RVTY
RVTY
Q4 25
1.10×
Q3 25
Q2 25
Q1 25
Q4 24
1.18×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PATK
PATK
RVTY
RVTY
Operating Cash FlowLast quarter
$130.8M
$182.0M
Free Cash FlowOCF − Capex
$112.7M
$161.8M
FCF MarginFCF / Revenue
12.2%
21.0%
Capex IntensityCapex / Revenue
2.0%
2.6%
Cash ConversionOCF / Net Profit
4.50×
1.85×
TTM Free Cash FlowTrailing 4 quarters
$246.5M
$509.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PATK
PATK
RVTY
RVTY
Q4 25
$130.8M
$182.0M
Q3 25
$9.1M
$138.5M
Q2 25
$149.4M
$134.3M
Q1 25
$40.1M
$128.2M
Q4 24
$102.7M
$174.2M
Q3 24
$51.5M
$147.9M
Q2 24
$137.5M
$158.6M
Q1 24
$35.2M
$147.6M
Free Cash Flow
PATK
PATK
RVTY
RVTY
Q4 25
$112.7M
$161.8M
Q3 25
$-17.2M
$120.0M
Q2 25
$131.1M
$115.5M
Q1 25
$19.9M
$112.2M
Q4 24
$77.2M
$149.8M
Q3 24
$33.7M
$125.6M
Q2 24
$120.6M
$136.6M
Q1 24
$19.7M
$129.7M
FCF Margin
PATK
PATK
RVTY
RVTY
Q4 25
12.2%
21.0%
Q3 25
-1.8%
17.2%
Q2 25
12.5%
16.0%
Q1 25
2.0%
16.9%
Q4 24
9.1%
20.5%
Q3 24
3.7%
18.4%
Q2 24
11.9%
19.7%
Q1 24
2.1%
20.0%
Capex Intensity
PATK
PATK
RVTY
RVTY
Q4 25
2.0%
2.6%
Q3 25
2.7%
2.6%
Q2 25
1.7%
2.6%
Q1 25
2.0%
2.4%
Q4 24
3.0%
3.4%
Q3 24
1.9%
3.3%
Q2 24
1.7%
3.2%
Q1 24
1.7%
2.7%
Cash Conversion
PATK
PATK
RVTY
RVTY
Q4 25
4.50×
1.85×
Q3 25
0.26×
2.97×
Q2 25
4.61×
2.49×
Q1 25
1.05×
3.03×
Q4 24
7.05×
1.84×
Q3 24
1.26×
1.57×
Q2 24
2.87×
2.87×
Q1 24
1.00×
5.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PATK
PATK

Recreational Vehicle$276.3M30%
Distribution$222.4M24%
Marine$141.9M15%
Industrial$110.8M12%
Powersports$104.8M11%
Manufactured Housing$67.9M7%

RVTY
RVTY

Immunodiagnostics$240.8M31%
Life Sciences$191.4M25%
Reproductive Health$149.3M19%
Segment Operating Income$132.0M17%
Software$62.3M8%

Related Comparisons